Cerebrolysin (60 mg Vial) Dosage Protocol

Quickstart Highlights

Cerebrolysin dosage protocols leverage this porcine brain-derived neuropeptide preparation containing low-molecular-weight peptides and free amino acids that cross the blood–brain barrier to support neuronal survival and neuroplasticity^[1]. By mimicking endogenous neurotrophic factors such as nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), Cerebrolysin may enhance cognitive function, support memory, and promote neuroprotection in age-related cognitive decline and stroke recovery^[2]^[3]. This educational protocol presents a once- to twice-daily subcutaneous approach using a practical dilution for clear insulin-syringe measurements.

Reconstitute: Add 3.0 mL bacteriostatic water to the 60 mg vial → 20 mg/mL concentration.

Typical daily range: 20–32 mg once or twice daily (gradual titration over 3–4 weeks).

Easy measuring: At 20 mg/mL, 1 unit = 0.01 mL = 200 mcg (0.2 mg) on a U-100 insulin syringe.

Storage: Lyophilized: store at ≤25 °C (77 °F) in dry, dark conditions; after reconstitution, refrigerate at 2–8 °C (36–46 °F) and use within 7 days. Do not freeze reconstituted solution.

Dosing & Reconstitution Guide

Educational guide for reconstitution and daily dosing

Standard / Gradual Titration Schedule (3 mL = 20 mg/mL)

Week	Daily Dose (mg)	Injection Schedule (Units & mL)
Week 1	20 mg	100 units (1.0 mL) once each morning
Week 2	24 mg	60 units (0.6 mL) AM + 60 units (0.6 mL) PM
Week 3	28 mg	70 units (0.7 mL) AM + 70 units (0.7 mL) PM
Week 4+	32 mg	80 units (0.8 mL) AM + 80 units (0.8 mL) PM

Frequency: Inject once daily subcutaneously in Week 1, then twice daily (morning and evening) from Week 2 onward to keep each injection ≤1.0 mL for optimal absorption^[4]. Morning administration is preferred for once-daily dosing due to Cerebrolysin’s mildly stimulatory properties^[5].

Reconstitution Steps

Draw 3.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming.

Gently swirl/roll until dissolved (do not shake).

Label with date/time and refrigerate at 2–8 °C (36–46 °F); use within 7 days.

Important: This guide is for educational purposes only and is not medical advice. For research use only. Not for human consumption.

Supplies Needed

Plan based on an 8–16 week daily protocol with gradual titration to 32 mg/day maintenance.

Peptide Vials (Cerebrolysin, 60 mg each):

8 weeks ≈ 28 vials
12 weeks ≈ 42 vials
16 weeks ≈ 58 vials

Insulin Syringes (U-100, 1 mL):

Week 1: 7 syringes (1/day)
Weeks 2+: 14 syringes/week (2/day)
8 weeks: ~105 syringes
12 weeks: ~161 syringes
16 weeks: ~217 syringes

Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for reconstitution.

8 weeks (28 vials): 84 mL → 9 × 10 mL bottles
12 weeks (42 vials): 126 mL → 13 × 10 mL bottles
16 weeks (58 vials): 174 mL → 18 × 10 mL bottles

Alcohol Swabs: Two per injection (vial stopper + skin).

8 weeks (~105 injections): ~210 swabs → 3 × 100-count boxes
12 weeks (~161 injections): ~322 swabs → 4 × 100-count boxes
16 weeks (~217 injections): ~434 swabs → 5 × 100-count boxes

View Supplier

Protocol Overview

Concise summary of the daily regimen.

Goal: Promote neuroprotection and neuronal survival by providing neurotrophic support via NGF/BDNF-mimetic activity^[1]^[6].

Schedule: Daily subcutaneous injections for 8–12 weeks (extend to 16 weeks if desired); clinical practice often uses multiple cycles per year^[5].

Dose Range: 20–32 mg per day with gradual titration over 3–4 weeks.

Reconstitution: 3.0 mL per 60 mg vial (20 mg/mL) for precise measurements.

Storage: Lyophilized at room temp; reconstituted refrigerated; never freeze after mixing.

Research Disclaimer